The effects of purine compounds on the isolated aorta of the frog Rana temporaria
- 1 March 1996
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 117 (5) , 873-878
- https://doi.org/10.1111/j.1476-5381.1996.tb15274.x
Abstract
1. In the isolated aorta of the frog, Rana temporaria, adenosine concentration-dependently, endothelium-independently relaxed adrenaline pre-constricted vessels. None of the adenosine analogues including D-5'-(N-ethylcarboxamide) adenosine (NECA), R- and S-N6-(2-phenylisopropyl) adenosine (R-and S-PIA) and 2-chloroadenosine (2-CA), or the more selective A1, A2 and A3 agonists cyclopentyladenosine (CPA), CGS 21680 and N6-(3-iodobenzyl) adenosine-5'-N-methylcarboxamide (IB-MECA) respectively, had any effect. 2. The non-selective adenosine antagonist, 8-p-sulphophenyl-theophylline (8-pSPT; 30 microM) failed to inhibit adenosine relaxations, as did NG-nitro-L-arginine methyl ester (L-NAME; 0.1 mM) and indomethacin (30 microM). 3. Adenosine 5'-triphosphate (ATP), alpha, beta-methylene ATP (alpha, beta-MeATP), beta, gamma-methylene ATP (beta, gamma-MeATP), 2-methylthio ATP (2-MeSATP) and uridine 5'-triphosphate (UTP) all concentration-dependently contracted the frog aorta. ATP and alpha, beta-MeATP were equipotent and more potent than UTP and beta, gamma-MeATP; 2-MeSATP had little activity. 4. The P2-purinoceptor antagonist, suramin (0.1 mM) inhibited contractions to alpha, beta-MeATP but not to ATP. Pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid (PPADS; 30 microM) also inhibited contractions to alpha, beta-MeATP but not to ATP. Contractions to ATP were, however, inhibited by indomethacin (30 microM). 5. In conclusion, in the frog aorta there appears to be a novel subclass of P1-purinoceptor mediating vasodilatation, although like the A3 subclass it is not blocked by methylxanthines; a P2-purinoceptor mediates vasconstriction which resembles a P2x subtype, based on the agonist potency of alpha, beta-MeATP being more potent than 2-MeSATP (UTP has moderate activity) and PPADS is an effective antagonist. There is no evidence for the presence of a P2y-purinoceptor, mediating vasodilatation, in this preparation.Keywords
This publication has 72 references indexed in Scilit:
- Is there a basis for distinguishing two types of P2-purinoceptor?Published by Elsevier ,2002
- Recent developments in the classification and functional significance of receptors for ATP and UTP, evidence for nucleotide receptorsLife Sciences, 1992
- Receptors for adenosine and adenine nucleotidesGeneral Pharmacology: The Vascular System, 1991
- Molecular cloning of a novel putative G‐protein coupled receptor expressed during rat spermiogenesisFEBS Letters, 1991
- Noradrenaline and ATP as cotransmitters in sympathetic nervesNeurochemistry International, 1990
- Dual Control of Local Blood Flow by PurinesaAnnals of the New York Academy of Sciences, 1990
- Constriction of the Smooth Muscle of Rat Tail and Femoral Arteries and Dog Saphenous Vein Is Induced by Uridine Triphosphate via ‘Pyrimidinoceptors’, and by Adenosine Triphosphate via P2x PurinoceptorsJournal of Vascular Research, 1990
- The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladderGeneral Pharmacology: The Vascular System, 1989
- Local Control of Blood Pressure by PurinesJournal of Vascular Research, 1987
- Extracellular Functions of Nucleotides in Heart and Blood VesselsAnnual Review of Physiology, 1985